daratumumab,talquetamab,teclistamab,pomalidomide
janssen,genmab
['trimm-2', 'mmsm', 'dara ']
#mmsm #asco23 plasma cell dyscrasia oral session - trimm-2 g3/4 infections ~ 1/4 of patients again concerning infections with bisepcific therapies though this maybe lower than tec+dara peripheral b cells seem to be preserved 
Assistant professor @UAMSMyeloma. Alumni heme/onc @bcmhouston, clinical research/biostat @UMich.Focus on plasma cell disorders & health disparities